V Multidyscyplinarna Konferencja Nauki o Leku

 on-line journal

Time
 Duration
 Type
 Presenting person
 Title

May 15th, Monday

09:00 Opening lecture Teresa Paszkowska-Reymer CAN A QUEST FOR A NEW DRUG OF POLISH ORIGIN BE SUCCESSFUL?
09:45 00:45:00 Invited Oral Jan Lubiński THE LATEST ADVANCES IN CLINICAL GENETICS OF BREAST CANCER.
10:50 00:20:00 Oral Andrzej J. Bojarski NEW DUAL 5-HT7/5-HT1A LIGANDS WITH ANTIDEPRESSANT AND ANXIOLYTIC-LIKE ACTIVITY
11:10 00:20:00 Oral Ryszard Andruszkiewicz NOVEL ANITIEPILEPTIC DRUG - DISCOVERY STORY AND PERSONAL REMARKS
11:30 00:20:00 Oral Lech Kozerski NMR INVESTIGATIONS OF HUMAN INSULIN AGGREGATION AND STRUCTURE
11:50 00:20:00 Oral Desmond O' Grady AUTOMATED DESIGN OF ROBUST BATCH COOLING CRYSTALLIZATION USING REAL TIME ANALYTICS LASENTEC FBRM AND ReactIR
12:10 00:20:00 Oral Katarzyna Kieć-Kononowicz DESIGN AND SYNTHESIS OF HAPTEN TO GENERATE CATALYTIC ANTIBODIES THAT REDUCE PENTOXIFYLLINE
12:30 00:20:00 Oral Agnieszka Bartoszek DIETARY INTERVENTION WITH RED BEET JUICE DURING CANCER CHEMOTHERAPY WITH DOXORUBICIN AS MEANS OF COMBATING TOXIC SIDE EFFECTS RESULTING FROM OXIDATIVE STRESS
15:00 00:45:00 Invited Oral Wanda Baer-Dubowska CANCER CHEMOPREVENTIVE AGENTS - DRUGS FOR THE 21st CENTURY ?
15:45 00:20:00 Oral Michał Fedoryński LARGE SCALE LABORATORY SYNTHESIS OF 1-(4-CHLOROPHENYL)-1-CYANOCYCLO- BUTANE - A SIBUTRAMINE PRECURSOR
16:05 00:20:00 Oral Zbigniew J. Kamiński AN APPLICATION OF THE ARRAY OF LIPIDATED OLIGOPEPTIDES RESEMBLING ARTIFICIAL RECEPTORS FOR MOLECULAR RECOGNITION. THE STUDIES ON THE LIPOPHLILICITY OF SOME PIPERAZINES
16:45 00:45:00 Invited Oral Waldemar Priebe THE DISCOVERY AND DEVELOPMENT OF BLOOD-BRAIN BARRIER (BBB) PENETRATING ANTHRACYCLINES FOR THE TREATMENT OF BRAIN TUMORS
17:30 00:20:00 Oral Ewa Augustynowicz-Kopeć THE IMPORTANCE OF THE TYPE OF ISONIAZID ACETYLATION IN MONITORING OF TUBERCULOSIS TREATMENT.
17:50 00:20:00 Oral Jadwiga Handzlik SEARCHING FOR OPTIMAL METHOD FOR SOLUBILITY PREDICTION AMONG BIOLOGICALLY ACTIVE PHENYLPIPERAZINE DERIVATIVES OF PHENYTOIN

May 16th, Tuesday

08:30 00:45:00 Invited Oral Ryszard S. Oliński DOES OXIDATIVE DAMAGE TO DNA AND ANTIOXIDANT STATUS HAVE CLINICAL SIGNIFICANCE?
09:15 00:45:00 Invited Oral Władysław Lasoń NEW PERSPECTIVES ON THE TREATMENT OF NEURODEGENERATIVE DISEASES
10:00 00:20:00 Oral Zofia Mazerska METABOLIC TRANSFORMATIONS OF ANTITUMOR AGENTS WITH CYTOCHROME P-450 ISOENZYMES.
10:20 00:20:00 Oral Dariusz Matosiuk STERICAL PREREQUISITES FOR PARTIAL ANTAGONISTS OF GLUTAMINERGIC GLUR5/6 RECEPTORS
11:00 00:20:00 Oral Grzegorz Węgrzyn GENE EXPRESSION-TARGETED ISOFLAVONE THERAPY FOR MUCOPOLYSACCHARIDOSES
11:20 00:20:00 Oral Anna Wardowska THE BIOLOGICAL ACTIVITY OF NEW TUFTSIN DERIVATIVES - INDUCTION OF PHAGOCYTOSIS.
11:40 00:20:00 Oral Piotr Polcyn NEW CORES FOR THE SYNTHESIS OF NEW GENERATION OF DENDRIMERIC PEPTIDES
12:00 00:20:00 Oral Barbara Szechner NEW SYNTHESIS OF REPAGLINIDE
14:30 00:45:00 Invited Oral Jerzy Ostrowski STRENGTHS AND LIMITATIONS OF INTEGRATIVE GENOMICS EXEMPLIFIED BY STUDIES OF BARRETT'S ESOPHAGUS
15:15 00:20:00 Oral Marek T. Konieczny CLICK CHEMISTRY? WE LIKE IT
15:35 00:20:00 Oral Magdalena Jasińska THE INFLUENCE OF SIMVASTATIN IN HIGH DOSE AND DILTIAZEM ON MYOCARDIUM IN RABBITS
16:15 00:45:00 Invited Oral Stanislaw Słomkowski NANOPARTICLES FROM POLYESTER-CONTAINING BLOCK COPOLYMERS AS CARRIERS OF BIOACTIVE COMPOUNDS
17:00 00:20:00 Oral Sławomir Milewski ANTIFUNGAL DRUGS AND MULTIDRUG RESISTANCE - AN OPEN PROBLEM
17:20 00:20:00 Oral Maria Kraj INCIDENCE OF JAW OSTEONECROSIS IN MYELOMA PATIENTS TREATED WITH BISPHOSPHONATES

May 17th, Wednesday
08:30 00:45:00 Invited Oral Renata Jachowicz RECENT TRENDS IN ORAL DRUG IMPROVEMENT
09:15 00:45:00 Invited Oral Jacek Gawroński ASYMMETRIC SYNTHESES AND TRANSFORMATIONS - TOOLS FOR CHIRALITY MULTIPLICATION IN DRUG SYNTHESIS
10:20 00:20:00 Oral Krystyna Gryz EUROPEAN CRITERIA FOR QUALITY ASSESSMENT OF CHEMICAL AND BIOLOGICAL MEDICINAL PRODUCTS DURING THE REGISTRATION PROCESS
11:00 00:45:00 Invited Oral Piotr T. Siedlecki FACTS AND MYTHS CONCERNING CLINICAL TRIALS OF ONCOLOGICAL DRUGS
14:30 00:45:00 Oral Marcin Grabowski PROGRESS IN CARDIOVASCULAR DISEASES TREATMENT
15:15 00:20:00 Oral Jolanta Obniska ANTICONVULSANT PROPERTIES AND 5-HT1A, 5-HT2A RECEPTOR AFFINITY OF NEW N-[(4-ARYLPIPERAZIN-1-YL)-ALKYL] - 2 - AZASPIRO[4.4]NONANE- AND [4.5]DECANE-1,3-DIONES
15:35 00:20:00 Oral Katarzyna Jelonek LONG-TERM CYCLOSPORINE A (CyA) AND SIROLIMUS RELEASE FROM BIODEGRADABLE MATRICES AS A RESULT OF OPTIMAL ADJUSTMENT OF COPOLYMER CHAIN MICROSTRUCTURE
15:55 00:20:00 Oral Krzysztof Jóźwiak MOLECULAR INTERACTIONS BETWEEN NICOTINIC ACETYLCHOLINE RECEPTOR AND ITS LIGANDS - CHROMATOGRAPHIC AND MODELING APPROACHES
16:15 00:20:00 Oral Krzysztof Kurowski MODULATION OF TRANSCRIPTIONAL ACTIVITY IN ADIPOSE TISSUE OF db/db MICE AFTER ORAL ADMINISTRATION OF NOVEL POTENTIAL ANTIDIABETIC DRUGS (AD10369, AD10371, AD10797, AD10798 AND AD101025).
16:35 00:20:00 Oral Ewa Leciejewicz-Ziemecka PHARMACOPOEIA - SET OF QUALITY REQUIREMENTS FOR MEDICINAL PRODUCTS
16:55 00:20:00 Oral Agnieszka Adamczyk NEW 3-ALKENYL DERIVATIVES OF RIFAMYCIN ANTIBIOTICS
© 1998-2024 pielaszek research, all rights reserved Powered by the Conference Engine